Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
The Global Healthy Living Foundation (GHLF) and Guardant Health today announced a new partnership aimed at improving public understanding of colorectal cancer and encouraging timely screening through ...
Penumbra, Inc. today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, ...
Veracyte, Inc. , a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 9:45 a.m.
Investor's Business Daily on MSN
Dow Jones futures: Techs fall as 2025's end nears; Tesla, Nvidia in focus
The stock market is right at record highs heading into the end of 2025. Nvidia, Google and Apple are all just above buy ...
The fund is an actively-managed exchange-traded fund (“ETF”) that invests primarily in equity securities of small-cap companies listed on a U.S. exchange and selected by Deepwater Asset Management, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback